Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$342,199,842
+$15,406,658 QoQ
Shares Held
3,677,591
+0.0% QoQ
Ownership
1.46%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#3
of 284 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dodge & Cox holds $6,173,089,929 across 5 Biotechnology names. BNTX ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,871,137 | $3,037,348,764 | |
| 2 | INCY |
Incyte Corp
|
11,957,326 | $1,355,482,475 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
14,844,930 | $849,426,894 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,955,393 | $588,631,954 | |
| 5 | BNTX |
BioNTech SE
This page
|
3,677,591 | $342,199,842 |
All Filings in BNTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $342,199,842 | 3,677,591 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $326,793,184 | 3,676,791 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $344,099,543 | 3,614,491 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $359,676,114 | 3,647,091 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $93,420,717 | 877,437 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||